-
Forskolin as a Translational cAMP Control Point
2026-09-10
Forskolin is more than a standard cAMP tool: as a direct type I adenylate cyclase activator, it can help translational researchers distinguish pathway sufficiency from receptor-dependent biology. This article connects its mechanistic profile with pancreatic ductal organoid development, stem cell differentiation, bone formation, neuroendocrine secretion, and cardiovascular disease research while defining practical controls and experimental limits.
-
Panoramic Hyperspectral Mapping of Cardiac Infarcts
2026-09-09
Kowalik and colleagues developed a co-registered imaging platform that combines panoramic hyperspectral classification of epicardial tissue with optical mapping of cardiac membrane potential. In perfused rat hearts with established infarcts, the method associated collagen-sensitive tissue classes with action-potential duration, premature ventricular contractions, and reentrant excitation, creating a structure–function framework for arrhythmia research.
-
CCT007093: A Practical PPM1D Inhibitor Workflow
2026-09-09
CCT007093 is a research-focused PPM1D inhibitor for connecting phosphatase activity with P38 kinase activation, cancer-cell responses, and inflammatory injury models. This workflow translates its DMSO handling, time-dependent signaling effects, and pharmacological rescue strategy into practical assay designs.
-
LC–MS/MS Maps GS-441524 Prodrug Conversion
2026-09-08
A January 2026 Microchemical Journal study established an LC–MS/MS workflow to trace conversion of the novel GS-441524 prodrug NGP-1 into GS441 in gastric, blood, microsomal, and rat in vivo systems. Its results suggest sequential conversion across gastrointestinal, hepatic, and circulating compartments, offering a practical framework for interpreting prodrug pharmacokinetics and guiding anti-SARS-CoV-2 nucleoside analog development.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-09-08
Use Lambda Protein Phosphatase to distinguish phosphorylation-dependent BMAL1 behavior from antibody artifacts, protein abundance, and condensate-buffer effects. This practical workflow combines paired dephosphorylation controls with phospho-antibody validation, phase-separation assays, and phosphorylation site validation.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-07
This study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links protein O-GlcNAc modification to iron uptake, ferroptosis, and trophoblast syncytialization in preeclampsia. Its findings suggest that stabilizing O-GlcNAcylated HUWE1 promotes TfR1 ubiquitination and degradation, thereby limiting iron-dependent trophoblast injury and improving pregnancy outcomes in mice.
-
Ataxin-3, CFTR, and Microglial Inflammation
2026-09-07
The reference study identifies an Ataxin-3–K63 ubiquitin chain–CFTR pathway that links polyglutamine-expanded Ataxin-3 to accelerated CFTR turnover and pro-inflammatory microglial activation. Its findings provide a mechanistic framework for studying SCA3-associated neuroinflammation while highlighting the importance of preserving protein abundance, ubiquitination, and phosphorylation-sensitive signals during biochemical analysis.
-
PAD4-IN-2 TFA: Tumor-Targeted Workflows
2026-09-05
PAD4-IN-2 TFA, also known as Compound 5i TFA, combines PAD4 inhibition with meta-phenylboronic acid-mediated tumor targeting for studies of NET biology, metastasis, and immune remodeling. This practical guide connects dose-response, uptake, H3cit, migration, and in vivo workflows while emphasizing controls that distinguish tumor-cell effects from neutrophil-mediated mechanisms.
-
Tolazoline for Islet and Airway Pharmacology
2026-09-04
Tolazoline is an α2-adrenergic receptor antagonist that also provides a useful functional probe of ATP-sensitive potassium channels in β-cell assays. This article translates the evidence into practical workflows for islet function research and in vitro airway smooth muscle studies, with controls that help distinguish receptor-mediated effects from ion-channel activity.
-
LC–MS/MS Traces GS-441524 Prodrug Activation
2026-09-04
A January 2026 Microchemical Journal study established an LC–MS/MS strategy to follow conversion of the novel GS-441524 prodrug NGP-1 into GS441 in gastric fluid, blood, liver microsomes, and liver-injury model rats. The work provides a matrix-resolved framework for interpreting prodrug stability, hepatic metabolism, systemic hydrolysis, and GS-441524 pharmacokinetics during preclinical development.
-
XAV-939: From Wnt Control to Translational Insight
2026-09-03
XAV-939, also known as NVP-XAV939, is more than a Wnt pathway probe. By inhibiting TNKS1/2, stabilizing axin, and influencing the Hippo-YAP network, it offers translational researchers a mechanistic framework for connecting pathway state with cancer, fibrosis, and bone biology.
-
Dibutyryl-cAMP, Sodium Salt in Astrocyte Reprogramming
2026-09-03
Explore how Dibutyryl-cAMP, sodium salt can strengthen assay design for astrocyte-to-motoneuron reprogramming without being mistaken for a replacement for transcription-factor cocktails. This evidence-led guide connects DBcAMP sodium salt, stage-specific readouts, and cAMP signaling pathway research.
-
Cell Lysis Buffer for WB and IP in Cancer Biology
2026-09-02
Mechanistic studies of cancer-associated fibroblasts increasingly depend on preserving native protein complexes, phosphorylation states, and tissue-specific signaling context. This thought-leadership article examines how Cell lysis buffer for WB and IP can support investigation of the ANGPTL4-IQGAP1 axis, mitochondrial metabolism, and chemoresistance in prostate cancer while offering practical guidance for Western blot, immunoprecipitation, and translational workflow design.
-
1-Myristoylglycerophosphocholine: Assay Logic
2026-09-02
1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, is more than a lipid reagent: it is a defined perturbation for separating lysophospholipid correlation from causality. This guide connects lipidomics, fibroblast activation, and smooth muscle assays while emphasizing species identity, controls, and interpretation.
-
PBS Liposomes for Reliable Macrophage Controls
2026-09-01
PBS Liposomes provide a non-depleting, phagocytosis-compatible comparator for separating clodronate-specific macrophage loss from effects caused by liposome delivery. This workflow-focused guide explains how to pair phosphate-buffered saline liposomes with clodronate liposomes, standardize handling, and troubleshoot ambiguous in vivo results.